Thalidomide-induced normalization of serum alanine aminotransferase levels in a patient with hepatitis C
โ Scribed by Jean-Pierre Raufman; Laura W. Lamps
- Book ID
- 119391641
- Publisher
- Nature Publishing Group
- Year
- 2001
- Tongue
- English
- Weight
- 27 KB
- Volume
- 96
- Category
- Article
- ISSN
- 0002-9270
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Approximately 30% of patients with chronic hepatitis C have normal serum alanine aminotransferase (ALT) levels and another 40% have ALT levels that are less than twice the upper limit of the normal range. Most patients with normal ALT levels have mild degrees of inflammation with mild or no fibrosis
surface antigen (HBsAg) but also in patients with "resolved" HBV infection. 5,6 In a retrospective analysis of lymphoma patients who were HBsAg-negative and anti-HBV core antigen (anti-HBc) positive, 5 of the 21 patients who received chemotherapy plus rituximab, an anti-CD20 antibody, developed hepa